Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 421 AL 435

Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?

Kovacs GG.

Prion. 2016 Sep 2;10(5):369-376. doi: 10.1080/19336896.2016.1228507.

Cathepsin D as a therapeutic target in Alzheimer's disease

Di Domenico F, Tramutola A, Perluigi M.

Expert Opin Ther Targets. 2016 Dec;20(12):1393-1395. doi: 10.1080/14728222.2016.1252334. Epub 2016 Nov 2.

Treatment of epilepsy for people with Alzheimer's disease

Liu J, Wang LN, Wu LY, Wang YP.

Cochrane Database Syst Rev. 2016 Nov 2;11(11):CD011922. doi: 10.1002/14651858.CD011922.pub2.

The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging

Nahálková J.

Mol Cell Biochem. 2016 Dec;423(1-2):187-196. doi: 10.1007/s11010-016-2836-5. Epub 2016 Oct 3.

TREMs in Alzheimer's disease: Genetic and clinical investigations

Cheng J, Guo X, Zhang T, Zhong L, Bu G, Chen X.

Clin Chim Acta. 2016 Dec 1;463:88-95. doi: 10.1016/j.cca.2016.10.022. Epub 2016 Oct 18.

The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease

Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N.

J Nutr Biochem. 2016 Dec;38:1-11. doi: 10.1016/j.jnutbio.2016.03.002. Epub 2016 Mar 24.

Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy

Sharma HS, Muresanu DF, Sharma A.

Neurodegener Dis Manag. 2016 Dec;6(6):453-456. doi: 10.2217/nmt-2016-0037. Epub 2016 Nov 9.

Network abnormalities and interneuron dysfunction in Alzheimer disease

Palop JJ, Mucke L.

Nat Rev Neurosci. 2016 Dec;17(12):777-792. doi: 10.1038/nrn.2016.141. Epub 2016 Nov 10.

The road to restoring neural circuits for the treatment of Alzheimer's disease

Canter RG, Penney J, Tsai LH.

Nature. 2016 Nov 10;539(7628):187-196. doi: 10.1038/nature20412.

The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions

Fargo KN, Carrillo MC, Weiner MW, Potter WZ, Khachaturian Z.

Alzheimers Dement. 2016 Nov;12(11):1113-1115. doi: 10.1016/j.jalz.2016.10.001.

Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review

Wang ZY, Liu JG, Li H, Yang HM.

Am J Chin Med. 2016;44(8):1525-1541. doi: 10.1142/S0192415X16500853. Epub 2016 Nov 16.

Pharmacotherapies for sleep disturbances in dementia

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ, Schelter BO, Davis CS, Staff RT, Bracoud L, Shamsi K, Storey JM, Harrington CR, Wischik CM.

Lancet. 2016 Dec 10;388(10062):2873-2884. doi: 10.1016/S0140-6736(16)31275-2. Epub 2016 Nov 16.

Dietary DHA and health: cognitive function ageing

Cardoso C, Afonso C, Bandarra NM.

Nutr Res Rev. 2016 Dec;29(2):281-294. doi: 10.1017/S0954422416000184. Epub 2016 Nov 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias